The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor

Leukemia

Volumn 14, Issue 7, 2000, Pages 1284-1291

  Ward, A C ^a,d   Oomen, S P M A ^a   Smith, L ^b,e   Gits, J ^a   Van Leeuwen, D ^b   Soede Bobok, A A ^a   Erpelinck Verschueren, C A J ^a   Yi, T ^c   Touw, I P ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LERNER RESEARCH INSTITUTE   (United States)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytokine receptors; G CSF; Granulopoiesis; Protein tyrosine phosphatases; Signal transduction

Indexed keywords

CYTOKINE RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; GRANULOCYTE; HEMATOPOIETIC SYSTEM; IN VITRO STUDY; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0033947111     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401822     Document Type: Article

References (59)

1. Nicola NA. Hemopoietic cell growth factors and their receptors. Ann Rev Biochem 1989; 58: 45-77.
2. Demetri GD, Griffin ID. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791-2808.
3. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor deficiency, and impaired neutrophil mobilization. Blood 1994; 84: 1737-1746.
4. Liu F, Wu HY, Wesselschmidt R, Kornaga T, Link DC. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 1996; 5: 491-501.
5. Fukunaga R, Ishizaka Ikeda E, Seto Y, Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 1990; 61: 341-350.
6. Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996; 88: 761-777.
7. Nicholson SE, Oates AC, Harpur AG, Ziemiecki A, Wilks AF, Layton JE. Tyrosine kinase JAK1 is associated with the granulocyte-colony stimulating factor receptor and both become tyrosine phosphorylated after receptor activation. Proc Natl Acad Sci USA 1994; 91: 2985-2988.
8. Tian S-S, Lamb P, Seidel HM, Stein RB, Rosen J. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 1994; 84: 1760-1764.
9. Nicholson SE, Starr R, Novak U, Hilton DJ, Layton JE. Tyrosine residues in the granulocyte colony-stimulating receptor (G-CSF-R) mediate G-CSF-induced differentiation of murine myeloid leukemic (M1) cells. J Biol Chem 1996; 271: 26947-26953.
10. Tian S-S, Tapley P, Sincich C, Stein RB, Rosen J, Lamb P. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STATS, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood 1996; 88: 4435-4444.
11. Barge RM, de Koning JP, Pouwels K, Dong F, Löwenberg B, Touw IP. Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route. Blood 1996; 87: 2148-2153.
12. de Koning JP, Dong F, Smith L, Schelen AM, Barge RM, van der Plas DC, Hoefsloot LH, Löwenberg B, Touw IP. The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood 1996; 87: 1335-1342.
13. Novak U, Ward AC, Hertzog PJ, Hamilton JA, Paradiso L. Aberrant activation of IAK/STAT pathway components in response to G-CSF, interferon-alpha/beta and interteron-gamma in NFS-60 cells. Growth factors 1996; 13: 251-260.
14. Shimoda K, Feng J, Murakami H, Nagata S, Watling D, Rogers NC, Stark GR, Kerr IM, Ihle JN. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 1997; 90: 597-604.
15. Ward AC, Hermans MHA, Smith L, van Aesch YM, Schelen AM, Antonissen C, Touw IP. Tyrosine-dependent and independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood 1999; 93: 113-124.
16. Ward AC, van Aesch YM, Schelen AM, Touw IP. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood 1999; 93: 447-458.
17. Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ. Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci USA 1994; 91: 4683-4687.
18. Corey SJ, Dombrosky-Ferlan PM, Zuo S, Krohn E, Donnenberg AD, Zorich P, Romero G, Takata M, Kurosaki T. Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor. J Biol Chem 1998; 273: 3230-3235.
19. Ward AC, Monkhouse JL, Csar XF, Touw IP, Bello PA. The Src-like kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF), and docks to the activated G-CSF receptor. Biochem Biophys Res Commun 1998; 251: 117-123.
20. ras/MAP kinase signalling pathway. Blood 1994; 83: 949-957.
21. Nicholson SE, Novak U, Ziegler SF, Layton JE. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42,p44 MAPK. Blood 1995; 86: 3698-3704.
22. Csar XF, Ward AC, Hoffmann BW, Guy GG, Hamilton JA. cAMP suppresses p21ras and Rat-1 responses but not the Erk-1 response to granulocyte-colony-stimulating factor: possible Raf-1-independent activation of Erk-1. Biochem J 1997; 322: 79-87.
23. Ward AC, Monkhouse JL, Hamilton JA, Csar XF. Direct binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptor. Biochim Biophys Acta 1998; 1448: 70-76.
24. Shen S, Bastien L, Posner BI, Chretien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 1991; 353: 736-739.
25. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992; 12: 2396-2405.
26. Plutzky I, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 1992; 89: 1123-1127.
27. Yi T, Cleveland IL, Ihle JN. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 1992; 12: 836-846.
28. Adachi M, Fischer EH, Ihle J, Imai K, Jirik F, Neel B, Pawson T, Shen S, Thomas M, Ullrich A, Zhao Z. Mammalian SH2-containing protein tyrosine phosphatases. Cell 1996; 85: 15.
29. Shultz LD. Pleiotropic effects of deleterious alleles at the 'motheaten' locus. Curr Top Microbiol Immunol 1988; 137: 126-222.
30. Van Zant G, Schultz LD. Hematopoietic abnormalitiles of the immunodelicient mouse mutant viable motheaten (mev). Exp Hematol 1989; 17: 81-87.
31. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 73: 1445-1454.
32. Tsui HW, Siminovitch KA, de Souza L, Tsui FW. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 1993; 4: 124-129.
33. Tapley P, Shevde NK, Schweitzer PA, Gallina M, Christianson SW, Lin IL, Stein RB, Shultz LD, Rosen J, Lamb P. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp Hamatol 1997; 25: 122-131.
34. Green MC, Shultz LD. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J Hered 1975; 66: 250-258.
35. Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL. 'Viable motheaten', a new allele at the motheaten locus. I. Pathology. Am J Pathol 1984; 116: 179-192.
36. Yi T, Ihle JN. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand. Mol Cell Biol 1993; 13: 3350-3358.
37. Yi T, Mui AL, Krystal G, Ihle JN. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 1993; 13: 7577-7586.
38. Yi T, Zhang J, Miura O, Ihle JN. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor alter Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Blood 1995; 85: 87-95.
39. Klingmüller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specitic recruitment ot SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferate signals. Cell 1995; 80: 729-739.
40. Migone T-S, Cacalano NA, Taylor N, Yi T, Waldmann TA, Johnston JA. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc Natl Acad Sci USA 1998; 95: 3845-3850.
41. Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch KA. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol 1998; 18: 2089-2099.
42. Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem 1995; 270: 18179-18182.
43. Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 1996; 16: 5985-6992.
44. Ram PA, Waxman DJ. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 1997; 272: 17694-17702.
45. Dong F, Brynes RK, Tidow N, Welte K, Löwenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. New Engl J Med 1995; 333: 487-493.
46. Palacios R, Steinmetz M. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 1985; 41: 727-734.
47. Ward AC, Castelli LA, Lucantoni AC. White JF, Azad AA, Macreadie IG. Expression and analysis of the NS2 protein of influenza A virus. Arch Virol 1995; 140: 2067-2073.
48. Laemmli UK. Cleavage of structural proteins during assembly of the head of phage T4. Nature 1970; 227: 680-685.
49. Vinson CR, LaMarco KL, Johnson PF, Landschulz WH, McKnight SL. In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. Genes Dev 1988; 2: 801-806.
50. Kaelin WG Jr, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 1992; 70: 351-364.
51. Saduwski HB, Gilman MZ. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature 1993; 362: 79-83.
52. Lamb P, Kessler LV, Suto C, Levy DE, Seidel HM, Stein RB, Rosen J. Rapid activation of proteins that interact with the interferon-g activation site in response to multiple cytokines. Blood 1994; 83: 2063-2071.
53. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 1990; 9: 4477-4484.
54. Wang D, Stravopodis D, Teglund S, Kitazawa J, Ihle JN. Naturally occurring dominant negative variants of Stat.5. Mol Cell Biol 1996; 16: 6141-6148.
55. Dong F, Liu X, de Koning JP, Touw IP, Henninghausen L, Larner A, Grimley PM. Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J Immunol 1998; 161: 6503-6509.
56. Ward AC, van Aesch YM, Gits I, Schelen AM, de Koning JP, van Leeuwen D, Freedman MH, Touw IP. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating facotr (G-CSF) receptor in a case of severe congenital neutropenia hypo-responsive to G-CSF treatment. J Exp Med 1999; 190: 497-507.
57. Zhao Z, Shen SH, Fischer EH. Phorbol ester-induced expression, phosphorylation, and translocation of protein-tyrosine-phosphatase 1C in HL-60 cells. Proc Natl Acad Sci USA 1994; 91: 5007-5011.
58. Uesugi Y, Fuse I, Toba K, Kishi K, Furukawa T, Koike T, Aizawa Y. Involvement of SHP-1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell lines. Eur J Hematol 1999; 62: 239-245.
59. Delibrias CC, Floettmann JE, Rowe M, Fearon DT. Downregulated expression of SHP-1 in Burkitt lyniphomas and germinal center B lymphocytes. J Exp Med 1997; 186: 1575-1583.